A Randomized, Open-label, Multiple-dose, 6×3 Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of JW0104 and C2207 in Healthy Adults
Latest Information Update: 25 Apr 2024
At a glance
- Drugs C 2207 (Primary) ; JW 0104 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors JW Pharmaceutical
Most Recent Events
- 25 Apr 2024 New trial record